NEW YORK (GenomeWeb News) – Beckman Coulter Life Sciences on Thursday announced the acquisition of the flow cytometry business assets of ReaMetrix India for an undisclosed amount.

Beckman Coulter LS said that the deal provides it with "temperature-stable, single-dose, multicolor antibody cocktails targeting the HIV monitoring and clinical research markets." It added that ReaMetrix's products complement its flow cytometry product portfolio with reagents that streamline the sample preparation process and provide standardized reagent combinations to cytometry labs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.